Advancing open science in Alzheimer’s disease clinical trials: Sharing of A4 and LEARN neuroimaging data
The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies were large, multicenter investigations designed to characterize preclinical Alzheimer’s disease (AD) and evaluate whether solanezumab could slow cogni...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Organization for Human Brain Mapping
2026-05-01
|
| Serie: | Aperture Neuro |
| Accesso online: | https://doi.org/10.52294/001c.160128 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|